2 insider filings
Ali Behbahani, insider filing for BDTX
Show all 2
- 4Insider filing for BDTX
- 4Insider filing for BDTX
Ali Behbahani, reporting
BDTX
Black Diamond Therapeutics, Inc. SEC filings
Every EDGAR filing for Black Diamond Therapeutics, Inc. (BDTX), newest first, with AI summaries and stories.
- Ticker
- BDTX
- CIK
- 1701541
- Latest filing
- Sep 21
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 16)
Filings
4Black Diamond Therapeutics, Inc.BDTXLIVE 10-QBlack Diamond Therapeutics, Inc.BDTXLIVE 8-KBlack Diamond Therapeutics, Inc.BDTXLIVE SCHEDULE 13GBlack Diamond Therapeutics, Inc.BDTXLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
SCHEDULE 13G/ABlack Diamond Therapeutics, Inc.BDTXLIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
4Black Diamond Therapeutics, Inc.BDTXLIVE 6 insider filings
Ali Behbahani, insider filing for BDTX
Show all 6
- 4Insider filing for BDTX
- 4Insider filing for BDTX
- 4Insider filing for BDTX
- 4Insider filing for BDTX
- 4Insider filing for BDTX
- 4Insider filing for BDTX
Ali Behbahani, reporting
8-KBlack Diamond Therapeutics, Inc.BDTXLIVE 4Black Diamond Therapeutics, Inc.BDTXLIVE 2 insider filings
Ali Behbahani, insider filing for BDTX
Show all 2
- 4Insider filing for BDTX
- 4Insider filing for BDTX
Ali Behbahani, reporting
8-KBlack Diamond Therapeutics, Inc.BDTXLIVE 10-QBlack Diamond Therapeutics, Inc.BDTXLIVE 8-KBlack Diamond Therapeutics, Inc.BDTXLIVE ARSBlack Diamond Therapeutics, Inc.BDTXLIVE DEFA14ABlack Diamond Therapeutics, Inc.BDTXLIVE DEF 14ABlack Diamond Therapeutics, Inc.BDTXLIVE 4Black Diamond Therapeutics, Inc.BDTXLIVE 2 insider filings
Ali Behbahani, insider filing for BDTX
Show all 2
- 4Insider filing for BDTX
- 4Insider filing for BDTX
Ali Behbahani, reporting
S-8Black Diamond Therapeutics, Inc.BDTXLIVE 10-KBlack Diamond Therapeutics, Inc.BDTXLIVE 8-KBlack Diamond Therapeutics, Inc.BDTXLIVE SCHEDULE 13G/ABlack Diamond Therapeutics, Inc.BDTXLIVE Ownership stake disclosure by Vestal Point Capital, LP (amended)
Vestal Point Capital, LP, filed by
4Black Diamond Therapeutics, Inc.BDTXLIVE 5 insider filings
Brent Hatzis-Schoch, insider filing for BDTX
Show all 5
- 4Insider filing for BDTX
- 4Insider filing for BDTX
- 4Insider filing for BDTX
- 4Insider filing for BDTX
- 4Insider filing for BDTX
Brent Hatzis-Schoch, reporting
4Black Diamond Therapeutics, Inc.BDTXLIVE 2 insider filings
Ali Behbahani, insider filing for BDTX
Show all 2
- 4Insider filing for BDTX
- 4Insider filing for BDTX
Ali Behbahani, reporting
EFFECTBlack Diamond Therapeutics, Inc.BDTXLIVE 8-KBlack Diamond Therapeutics, Inc.BDTXLIVE S-3Black Diamond Therapeutics, Inc.BDTXLIVE Black Diamond Therapeutics, Inc. filed an S-3 registration statement to efficiently raise capital by offering various securities to the public.
10-QBlack Diamond Therapeutics, Inc.BDTXLIVE 8-KBlack Diamond Therapeutics, Inc.BDTXLIVE